Sekine Ryoya, Takeda Kouki, Suenaga Tsukasa, Tsuno Satsuki, Kaiya Takumi, Kiso Maki, Yamayoshi Seiya, Takaku Yoshihide, Ohno Shiho, Yamaguchi Yoshiki, Nishizawa Seiichi, Sumitomo Kazuhiro, Ikuta Kazufumi, Kanda Teru, Kawaoka Yoshihiro, Nishimura Hidekazu, Kuge Shusuke
Division of Microbiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1, Komatsuhima, Aoba-ku, Sendai, Miyagi, 981-8558, Japan.
Division of Virology, Institute of Medical Sciences, The University of Tokyo, 4-6-1 Shiroganedai, Minato-ku, Tokyo, 108-8639, Japan.
Commun Biol. 2025 Jan 15;8(1):27. doi: 10.1038/s42003-024-07351-7.
Future pandemic threats may be caused by novel coronaviruses and influenza A viruses. Here we show that when directly added to a cell culture, 12mer guanine RNA (G12) and its phosphorothioate-linked derivatives (G12(S)), rapidly entered cytoplasm and suppressed the propagation of human coronaviruses and influenza A viruses to between 1/100 and nearly 1/1000 of normal virus infectivity without cellular toxicity and induction of innate immunity. Moreover, G12(S) alleviated the weight loss caused by coronavirus infection in mice. G12(S) might exhibit a stable G-tetrad with left-handed parallel-stranded G-quadruplex, and inhibit the replication process by impeding interaction between viral nucleoproteins and viral RNA in the cytoplasm. Unlike previous antiviral strategies that target the G-quadruplexes of the viral genome, we now show that excess exogenous G-quadruplex-forming small RNA displaces genomic RNA from ribonucleoprotein, effectively inhibiting viral replication. The approach has the potential to facilitate the creation of versatile middle-molecule antivirals featuring lipid nanoparticle-free delivery.
未来的大流行威胁可能由新型冠状病毒和甲型流感病毒引起。我们在此表明,当直接添加到细胞培养物中时,12聚体鸟嘌呤RNA(G12)及其硫代磷酸酯连接的衍生物(G12(S))能迅速进入细胞质,并将人类冠状病毒和甲型流感病毒的繁殖抑制到正常病毒感染性的1/100至近1/1000,且无细胞毒性和诱导先天免疫。此外,G12(S)减轻了小鼠冠状病毒感染引起的体重减轻。G12(S)可能呈现出具有左手平行链G-四链体的稳定G-四联体,并通过阻碍病毒核蛋白与细胞质中病毒RNA之间的相互作用来抑制复制过程。与以往针对病毒基因组G-四链体的抗病毒策略不同,我们现在表明,过量的外源性形成G-四链体的小RNA会从核糖核蛋白中取代基因组RNA,有效抑制病毒复制。该方法有可能促进创建具有无脂质纳米颗粒递送特点的通用中分子抗病毒药物。